New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
Malignant neoplasms
Malignant Neoplasms
Primary cancers of the salivary gland are uncommon, but not rare. Just as a benign tumor does, they often present as a painless enlarging mass that may or may not be associated with neck lymph node metastases.
About 20% of parotid tumors are malignant, with higher percentages for children, for the submandibular gland, and for intraoral minor salivary glands.
A diagnosis is generally made possible via a fine needle biopsy (FNA). Imaging (MRI) helps define its extent in the neck.
A PET-CT or chest CT may be ordered to assess for distant spread. The stage is defined by the size of the tumor, presence of neck metastases, presence of distant spread (uncommon for most tumors) and whether there is facial weakness.
Learn more about diagnosing salivary gland cancer.
Broadly speaking, salivary gland malignancies are grouped into low grade and high grade cancers. Low grade cancers have a very good prognosis, and are often cured with surgery alone. Long-term follow-up is required need to ensure early intervention should there be a recurrence, which can occur years later.
The pathologies listed below are among the more common malignancies seen. They may arise from the parotid, submandibular gland or minor salivary glands. In some instances a cancer in the parotid may have actually spread to an intraparotid lymph node from elsewhere (such as from a facial skin squamous cell skin cancer or a melanoma) or such a metastasis may rarely even arise from farther away. Rarely a tumors may be malignant transformation from a prior benign tumor (as in a carcinoma arising within a prior benign pleomorphic adenoma).
Low grade tumors:
- Acinic cell adenocarcinoma
- Low grade mucoepidermoid carcinoma (some also describe an intermediate grade, which largely behaves similarly)
- Polymorphous low-grade adenocarcinoma (in palate)
- Epithelial-myoepithelial carcinoma
- Adenoid cystic carcinoma
High grade tumors:
- High grade mucoepidermoid carcinoma
- Carcinoma-ex pleomorphic adenoma
- Salivary duct carcinoma
- Adenocarcinoma
Metastases:
- Squamous cell skin cancer (a primary squamous cell carcinoma may theoretically also occur)
- Melanoma
- Other metastases
Other:
- Lymphoma arising within gland or involve periparotid lymph nodes
Intervention usually require surgery as first step. A low grade small malignancy may require only surgery, with surgery as described for benign parotid tumors. If in the submandibular gland, the gland is removed; likely along with upper neck nodes, a procedure with few likely side effects. A neck dissection (removal of nodes in the neck) will be done if nodes are involved in either a parotid or submandibular gland malignancy and may be recommended for some high grade tumors where the nodes are at risk.
Irradiation after surgery is recommended for larger low grade malignancies (greater than 4 cm.) and all high grade malignant tumors. Irradiation may include the neck nodes on the same side of the malignancy if either there were nodes involved or nodes are at risk for developing metastases. Chemotherapy may play a role as a radiosensitizer or when there is distant spread. Chemotherapy as a radiosensitizer (making the irradiation possibly more effective) may be discussed within a clinical trial.
Stanford head and neck tumor board
The Stanford comprehensive multidisciplinary head and neck tumor board meets weekly to review the imaging and pathology of all new patients (and existing patients with new problems). It comprises of members of different specialties with a common clinical focus on head and neck cancers, including:
- Head and neck surgeons
- Medical oncologists
- Radiation oncologists
- Nutritionists
- Speech therapists
- Radiologists
- Pathologists
Individualized treatments options are tailored for each patient, including the applicability of available clinical trials, and are then discussed with each patient.
As with low grade cancers, long-term follow-up is required need to facilitate consideration of intervention should there be a recurrence in the neck of a distant metastasis.
We treat all salivary cancers, including patients that have failed prior treatments. In revision parotid cancers that have been previously radiated, intraoperative radiotherapy may be indicated (irradiation to the area of concern done at the time of surgery, such that the skin in not irradiated and critical structures may at times be able to be shielded).
Reconstruction after parotid cancer surgery is an important aspect of any cancer surgery.
The face is important to a person's identity. Patients with facial nerve paralysis as a result of a high-grade salivary cancer receive facial nerve reconstruction at the time of their cancer surgery.
Facial nerve reconstruction options include:
- Gold or platinum implant to the upper eyelid
- Lower eyelid tightening
- Static lower face sling
- Masseter transfer to the lower face
- Temporalis muscle transfer to the lower face
- Facial nerve grafting
To restore volume loss (cheek hallowing) after parotid surgery, we offer the following reconstructive techniques:
- Sternocleidomastoid muscle flap
- Free flaps
- Fat grafts
- Digastric flap
- Temporalis or temporoparietal flap
Meet our team of experts at the Stanford Head and Neck Cancer Program.
INTERESTED IN AN ONLINE SECOND OPINION?
The Stanford Medicine Online Second Opinion program offers you easy access to our world-class doctors. It’s all done remotely, and you don’t have to visit our hospital or one of our clinics for this service. You don’t even need to leave home!
Visit our online second opinion page to learn more.
Condition Spotlight
Clinical Trials
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.